InnoCare Pharma Limited 諾誠健華醫藥有限公司

Pay for financial year ended 2020-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chen, Kaixian 陳凱先 INED
2 Cui, Jisong 崔霽松 Ch, CEO 780 2,351 116 3,247
3 Fu, Shan 付山 NED
4 Hu, Lan (1971) 胡蘭 INED
5 Lin, Lijun (SFC:AUJ216) 林利軍 NED
6 Shi, Yigong (1967) 施一公 NED
7 Yuan, Quanhong 苑全紅 NED
8 Zhang, Jason Zemin 張澤民 INED 83 83
9 Zhao, Renbin 趙仁濱 ED 1,308 39 14 1,361
Total 863 3,659 0 39 130 4,691

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 985 7,479 4,375 86 11,886 24,811 Report
2023-12-31 800 7,254 4,579 69 14,779 27,481 Report
2022-12-31 0 6,409 3,888 96 16 10,409 Report
2021-12-31 38 4,469 2,304 90 24 6,925 Report
2020-12-31 863 3,659 0 39 130 4,691 Report
2019-12-31 294 3,799 0 88 31 4,212 Report
Total 2,980 33,069 15,146 468 26,866 78,529

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Webb-site.com was originally created by David M Webb MBE

We are committed to maintaining high quality and expanding the database with additional data and insight.

Back to top